Colorectal cancer stool characteristics
Pro Research Analysisby 
Searched over 200M research papers
Stool-Based Biomarkers and Glycoproteomics in Colorectal Cancer
Stool characteristics in colorectal cancer (CRC) extend beyond visible changes and include molecular and biochemical alterations. Research has identified specific glycoproteins, such as the T-antigen, which are present in the stool of patients with both pre-cancerous lesions and CRC. High T-antigen expression is particularly associated with advanced disease and distant metastases. Proteomic analyses have revealed that a significant proportion of stool proteins in CRC patients show altered glycosylation patterns, and these changes are linked to immune response processes. These findings suggest that stool glycoproteomics could improve non-invasive CRC detection and screening methods 13.
Proteomic and Biochemical Stool Changes in CRC
Comprehensive proteomic screening of CRC stool samples has identified numerous proteins that are elevated compared to healthy controls. Notably, proteins such as MMP-8, MMP-9, haptoglobin, myeloperoxidase, fibrinogen, and PGRP-S are significantly increased in CRC and advanced adenomas. These proteins outperform hemoglobin in distinguishing CRC and advanced adenomas from healthy individuals, highlighting their potential as novel stool-based biomarkers for early detection . Additionally, CRC patients tend to have higher stool cholesterol levels, which is associated with dietary patterns high in fat and protein .
Microbiome and Metabolome Alterations in CRC Stool
The stool microbiome in CRC patients shows distinct differences compared to healthy individuals. There is a reduction in butyrate-producing bacteria and an increase in mucin-degrading species like Akkermansia muciniphila. Metabolically, CRC stools have higher acetate and amino acid concentrations, while healthy stools contain more butyrate, polyunsaturated fatty acids, and ursodeoxycholic acid. These changes in the microbiome and metabolome may influence CRC development and progression 489.
Visual and Physical Stool Characteristics
Clinically, CRC often presents with changes in stool habits, such as diarrhea being more common than constipation, and rectal bleeding. These symptoms are frequently reported by patients, especially younger individuals, and often persist for several months before diagnosis. Most CRC cases are symptomatic at presentation, with multiple symptoms being the norm . Routine stool tests in CRC patients also show distinct characteristics, including a higher rate of occult blood, which, when combined with serum tumor markers, improves diagnostic accuracy 610.
Imaging and Differentiation of Tumor vs. Stool
Advanced imaging techniques, such as dual-energy CT (DECT), can differentiate between colorectal tumors and stool based on density and visual patterns. Tumors typically show a homogeneous pattern and higher density on iodine maps, while stool is more heterogeneous and less dense, aiding in accurate diagnosis and staging .
Functional Impact of CRC Stool on Carcinogenesis
Experimental studies have shown that stool from CRC patients can promote tumorigenesis when introduced into mice, leading to increased polyp formation, dysplasia, and inflammation. This suggests that the altered microbiota and molecular content of CRC stool can directly contribute to cancer development .
Conclusion
Colorectal cancer is associated with a range of stool characteristics, from visible changes in bowel habits and occult blood to complex molecular, proteomic, and microbiome alterations. Advances in stool-based biomarkers, glycoproteomics, and imaging are enhancing the ability to detect CRC non-invasively and at earlier stages. Understanding these stool characteristics is crucial for improving screening, diagnosis, and potentially even prevention of colorectal cancer 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic